Literature DB >> 27061753

A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria.

Ran-Jing Tan1,2, He-Qiang Sun2, Wei Zhang1, Han-Mei Yuan2, Bin Li2, Hong-Tao Yan1, Chun-Hui Lan3, Jun Yang3, Zhuo Zhao2, Jin-Jin Wu1, Chao Wu2.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) seem to involve in the etiology of chronic spontaneous urticaria (CSU). But studies of the pathogenic mechanism are very little.
METHODS: In this study, we detected the serum-specific anti-H. pylori IgG and IgE antibodies in 211 CSU and 137 normal subjects by enzyme-linked immunosorbent assay (ELISA), evaluated the direct activation effects of H. pylori preparations and its protein components on human LAD2 mast cell line in vitro, and analyzed the specific protein ingredients and functions of the most effective H. pylori mixed protein component using liquid chromatography-mass spectrometry and ELISA assay.
RESULTS: In CSU patients, the positive rate of anti-H. pylori IgG positive rate was significantly higher than that in normal controls, and the anti-H. pylori IgE levels had no statistical difference between H. pylori-infected patients with and without CSU. Further studies suggested that H. pylori preparations can directly activate human LAD2 mast cell line in a dose-dependent manner and its most powerful protein component was a mixture of 21-35 kDa proteins. Moreover, the 21-35 kDa mixed protein component mainly contained 23 kinds of proteins, which can stimulate the release of histamine, TNF-a, IL-3, IFN-γ, and LTB4 by LAD2 cells in a dose-dependent or time-dependent manner.
CONCLUSIONS: A 21-35 kDa mixed protein component should be regarded as the most promising pathogenic factor contributing to the CSU associated with H. pylori infection.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; Chronic spontaneous urticaria; activation effect; mast cells; mixed protein component

Mesh:

Substances:

Year:  2016        PMID: 27061753     DOI: 10.1111/hel.12312

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

Review 1.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

2.  Management of chronic urticaria in children: a clinical guideline.

Authors:  Carlo Caffarelli; Francesco Paravati; Maya El Hachem; Marzia Duse; Marcello Bergamini; Giovanni Simeone; Massimo Barbagallo; Roberto Bernardini; Paolo Bottau; Filomena Bugliaro; Silvia Caimmi; Fernanda Chiera; Giuseppe Crisafulli; Cristiana De Ranieri; Dora Di Mauro; Andrea Diociaiuti; Fabrizio Franceschini; Massimo Gola; Amelia Licari; Lucia Liotti; Carla Mastrorilli; Domenico Minasi; Francesca Mori; Iria Neri; Aurelia Pantaleo; Francesca Saretta; Carlo Filippo Tesi; Giovanni Corsello; Gian Luigi Marseglia; Alberto Villani; Fabio Cardinale
Journal:  Ital J Pediatr       Date:  2019-08-15       Impact factor: 2.638

3.  Role of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: A Propensity Score Matching Analysis.

Authors:  Yan Guo; Hua-Ming Li; Wei-Qin Zhu; Zhen Li
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-05

Review 4.  The Effects of Antibiotics for Helicobacter pylori Eradication or Dapsone on Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.

Authors:  Jun Watanabe; Junya Shimamoto; Kazuhiko Kotani
Journal:  Antibiotics (Basel)       Date:  2021-02-04

5.  Immunodominant antigens that induce Th1 and Th17 responses protect mice against Helicobacter pylori infection.

Authors:  Heqiang Sun; Hanmei Yuan; Ranjing Tan; Bin Li; Gang Guo; Jinyong Zhang; Haiming Jing; Yi Qin; Zhuo Zhao; Quanming Zou; Chao Wu
Journal:  Oncotarget       Date:  2018-01-03

6.  Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis.

Authors:  Yi-Pin Lv; Yong-Sheng Teng; Fang-Yuan Mao; Liu-Sheng Peng; Jin-Yu Zhang; Ping Cheng; Yu-Gang Liu; Hui Kong; Ting-Ting Wang; Xiao-Long Wu; Chuan-Jie Hao; Weisan Chen; Shi-Ming Yang; Yong-Liang Zhao; Bin Han; Qiang Ma; Quan-Ming Zou; Yuan Zhuang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

7.  Eradication of Helicobacter pylori, as add-on therapy, has a significant, but temporary influence on recovery in chronic idiopathic urticaria: a placebo-controlled, double blind trial in the Polish population.

Authors:  Robert Pawłowicz; Krzysztof Wytrychowski; Bernard Panaszek
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.